Ethan B. Holland

Over 56,100 manually organized AI links and counting

AI Science and Medicine News: Week Ending 01/19/2024

January 20, 2024

Science/Medicine

This is MedivisAR: FDA-cleared, AI-powered Augmented Reality platform for surgeries. Imagine surgeons navigating with unparalleled clarity and precision, transforming how operations are performed. This isn’t just the future of surgery; it’s the future of healthcare excellence.

This is MedivisAR: FDA-cleared, AI-powered Augmented Reality platform for surgeries.

Imagine surgeons navigating with unparalleled clarity and precision, transforming how operations are performed. This isn't just the future of surgery; it's the future of healthcare excellence. pic.twitter.com/afGki5GmzK
— Mindaugas Galvosas, MD (@MGalvosas) January 20, 2024

Using AI, MIT researchers identify a new class of antibiotic candidates

These compounds can kill methicillin-resistant Staphylococcus aureus (MRSA), a bacterium that causes deadly infections.

https://www.freethink.com/health/ai-antibiotics

Seeing the unseen with AI-powered health monitoring

A short video on how powerful acoustic AI models transform simple bodily sounds, such as cough, into a symphony of rich and actionable data for health and wellness breakthroughs.

Seeing the unseen with AI-powered health monitoring

A short video on how powerful acoustic AI models transform simple bodily sounds, such as cough, into a symphony of rich and actionable data for health and wellness breakthroughs. pic.twitter.com/EWXqtcifyh
— Mindaugas Galvosas, MD (@MGalvosas) January 19, 2024

Machine learning hunt finds hundreds of new cancer targets, many with biomarkers to boot

Machine learning hunt finds hundreds of new cancer targets, many with biomarkers to boot #AI #machinelearning #drugdiscovery https://t.co/h3RtsHNKVB
— Arturo LoAIza-Bonilla, MD MSEd (@DrBonillaOnc) January 17, 2024

FDA just cleared the first AI device detecting all major skin cancer by DermoSensor.

Its pivotal trial showed sensitivity of 96% and a 97% chance of accurately identifying a skin lesion as benign. Notably, the approval process began back in 2016.

FDA just cleared the first AI device detecting all major skin cancer by DermoSensor.

Its pivotal trial showed sensitivity of 96% and a 97% chance of accurately identifying a skin lesion as benign.

Notably, the approval process began back in 2016. pic.twitter.com/DgzaURlchD
— Mindaugas Galvosas, MD (@MGalvosas) January 18, 2024

https://www.dermasensor.com

Study finds AI-driven eye exams increase screening rates for youth with diabetes

Johns Hopkins Children’s Center investigators say AI-driven cameras that take images of the back of the eye and require no eye drops can be used to close care gaps

https://www.eurekalert.org/news-releases/1030941

ID of five subtypes of Alzheimer’s has huge implications for treatmenthttps://newatlas.com/medical/five-subtypes-alzheimers-identified/

Be Sure To Read “This Week in AI“

This week’s executive overview and top links are here:
AI News #16: Week Ending 01/19/2024 with Executive Summary and Top 16 Stories

This is an extension of my weekly newsletter, This Week In AI, an executive summary of the top things to know in AI. Each week, I create an accessible overview for laypeople to feel confident they are conversant with the week’s AI developments. I include a curated list of must-click links of the week, to offer everyone a hands-on opportunity to explore the most intriguing updates in artificial intelligence across various categories, including robotics, imagery, video, AR/VR, science, ethics, and more. Beyond the overview, I post these topic-based deeper dives (below). If you haven’t read this week’s overview, I recommend starting there.